BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 19713933)

  • 1. Wip1 confers G2 checkpoint recovery competence by counteracting p53-dependent transcriptional repression.
    Lindqvist A; de Bruijn M; Macurek L; Brás A; Mensinga A; Bruinsma W; Voets O; Kranenburg O; Medema RH
    EMBO J; 2009 Oct; 28(20):3196-206. PubMed ID: 19713933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase.
    Yoda A; Toyoshima K; Watanabe Y; Onishi N; Hazaka Y; Tsukuda Y; Tsukada J; Kondo T; Tanaka Y; Minami Y
    J Biol Chem; 2008 Jul; 283(27):18969-79. PubMed ID: 18482988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polo-like kinase 1 phosphorylation of G2 and S-phase-expressed 1 protein is essential for p53 inactivation during G2 checkpoint recovery.
    Liu XS; Li H; Song B; Liu X
    EMBO Rep; 2010 Aug; 11(8):626-32. PubMed ID: 20577264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.
    Lu X; Ma O; Nguyen TA; Jones SN; Oren M; Donehower LA
    Cancer Cell; 2007 Oct; 12(4):342-54. PubMed ID: 17936559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint.
    Kleiblova P; Shaltiel IA; Benada J; Ševčík J; Pecháčková S; Pohlreich P; Voest EE; Dundr P; Bartek J; Kleibl Z; Medema RH; Macurek L
    J Cell Biol; 2013 May; 201(4):511-21. PubMed ID: 23649806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chk1 instability is coupled to mitotic cell death of p53-deficient cells in response to virus-induced DNA damage signaling.
    Jurvansuu J; Fragkos M; Ingemarsdotter C; Beard P
    J Mol Biol; 2007 Sep; 372(2):397-406. PubMed ID: 17663993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase.
    Shreeram S; Hee WK; Demidov ON; Kek C; Yamaguchi H; Fornace AJ; Anderson CW; Appella E; Bulavin DV
    J Exp Med; 2006 Dec; 203(13):2793-9. PubMed ID: 17158963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FRET-Based Sorting of Live Cells Reveals Shifted Balance between PLK1 and CDK1 Activities During Checkpoint Recovery.
    Lafranchi L; Müllers E; Rutishauser D; Lindqvist A
    Cells; 2020 Sep; 9(9):. PubMed ID: 32961751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wee1 inhibition potentiates Wip1-dependent p53-negative tumor cell death during chemotherapy.
    Clausse V; Goloudina AR; Uyanik B; Kochetkova EY; Richaud S; Fedorova OA; Hammann A; Bardou M; Barlev NA; Garrido C; Demidov ON
    Cell Death Dis; 2016 Apr; 7(4):e2195. PubMed ID: 27077811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct phosphatases antagonize the p53 response in different phases of the cell cycle.
    Shaltiel IA; Aprelia M; Saurin AT; Chowdhury D; Kops GJ; Voest EE; Medema RH
    Proc Natl Acad Sci U S A; 2014 May; 111(20):7313-8. PubMed ID: 24711418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of wild-type p53-induced phosphatase 1 (Wip1) plays a critical role in regulating several p53-dependent functions in premature senescent tumor cells.
    Crescenzi E; Raia Z; Pacifico F; Mellone S; Moscato F; Palumbo G; Leonardi A
    J Biol Chem; 2013 Jun; 288(23):16212-16224. PubMed ID: 23612976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53-Independent expression of wild-type p53-induced phosphatase 1 (Wip1) in methylmethane sulfonate-treated cancer cell lines and human tumors.
    Park JY; Song JY; Kim HM; Han HS; Seol HS; Jang SJ; Choi J
    Int J Biochem Cell Biol; 2012 Jun; 44(6):896-904. PubMed ID: 22405851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints.
    Lu X; Nannenga B; Donehower LA
    Genes Dev; 2005 May; 19(10):1162-74. PubMed ID: 15870257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of the ATM/ATR-mediated DNA damage response by the oncogenic phosphatase PPM1D.
    Lu X; Nguyen TA; Donehower LA
    Cell Cycle; 2005 Aug; 4(8):1060-4. PubMed ID: 15970689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase.
    Fujimoto H; Onishi N; Kato N; Takekawa M; Xu XZ; Kosugi A; Kondo T; Imamura M; Oishi I; Yoda A; Minami Y
    Cell Death Differ; 2006 Jul; 13(7):1170-80. PubMed ID: 16311512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wip1 regulates the generation of new neural cells in the adult olfactory bulb through p53-dependent cell cycle control.
    Zhu YH; Zhang CW; Lu L; Demidov ON; Sun L; Yang L; Bulavin DV; Xiao ZC
    Stem Cells; 2009 Jun; 27(6):1433-42. PubMed ID: 19489034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of Wip1 sensitizes cells to stress- and DNA damage-induced apoptosis.
    Xia Y; Ongusaha P; Lee SW; Liou YC
    J Biol Chem; 2009 Jun; 284(26):17428-37. PubMed ID: 19395378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Polo-like kinase 1 by DNA damage in mitosis. Inhibition of mitotic PLK-1 by protein phosphatase 2A.
    Jang YJ; Ji JH; Choi YC; Ryu CJ; Ko SY
    J Biol Chem; 2007 Jan; 282(4):2473-82. PubMed ID: 17121863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased wild-type p53-induced phosphatase 1 (Wip1 or PPM1D) expression correlated with downregulation of checkpoint kinase 2 in human gastric carcinoma.
    Fuku T; Semba S; Yutori H; Yokozaki H
    Pathol Int; 2007 Sep; 57(9):566-71. PubMed ID: 17685927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATM/Wip1 activities at chromatin control Plk1 re-activation to determine G2 checkpoint duration.
    Jaiswal H; Benada J; Müllers E; Akopyan K; Burdova K; Koolmeister T; Helleday T; Medema RH; Macurek L; Lindqvist A
    EMBO J; 2017 Jul; 36(14):2161-2176. PubMed ID: 28607002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.